CompletedNCT06817356
A Study to Evaluate Mazdutide Compared With Placebo in Participants With Addiction
Medication studyAges 21–65United States
Understand this study
Who was this study for?
Listed age limits: 21 years to 65 years.
- Listed locations
- Scottsdale and 24 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: February 6, 2025
- Recruitment status
- Completed
- Enrollment listed in the registry
- 308
- Sponsor
- Eli Lilly and Company
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT06817356
- Official title
Show the full official title
A Phase 2, Double-Blind, Proof of Concept Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder
Get this study by email
Recruitment & locations
CompletedScottsdale · Rogers · Fountain Valley
20 more locations
- Lemon Grove
- San Diego
- Hollywood
- Maitland
- Orlando
- Tampa
- Decatur
- Mandeville
- Watertown
- Worcester
- Las Vegas
- Staten Island
- Syracuse
- The Bronx
- Portland
- East Providence
- Charleston
- Memphis
- Dallas
- Richardson
Questions about this study
Who is behind this study?
The study sponsor is Eli Lilly and Company.
Did this study involve medication?
Yes. The study involved medication, including Mazdutide and Placebo.
Who was this study for?
Listed age limits: 21 years to 65 years.
